Sarcopenia in heart failure: mechanisms and therapeutic strategies

Area of Science:

• Geriatrics
• Cardiology
• Muscle Physiology

Background:

• Chronic heart failure (CHF) is a common condition in the elderly, often leading to muscle mass and strength loss.
• Sarcopenia, a geriatric syndrome, is increasingly recognized for its association with adverse health outcomes.
• The interplay between CHF and sarcopenia warrants investigation due to shared pathophysiological mechanisms.

Purpose of the Study:

• To review the relationship between chronic heart failure and sarcopenia.
• To explore shared pathophysiological pathways connecting these conditions.
• To discuss potential therapeutic strategies for managing muscle wasting in CHF patients.

Main Methods:

• Literature review focusing on the connection between CHF and sarcopenia.
• Analysis of shared pathophysiological mechanisms including malnutrition, inflammation, endocrine imbalances, and oxidative stress.
• Examination of muscular alterations such as ubiquitin proteasome system, myostatin signaling, and apoptosis.

Main Results:

• Malnutrition, systemic inflammation, endocrine imbalances, and oxidative stress are identified as key links between sarcopenia and CHF.
• Muscular alterations including the ubiquitin proteasome system, myostatin signaling, and apoptosis are implicated in muscle loss in both conditions.
• Several therapeutic avenues are proposed, including nutritional and vitamin supplementation, physical exercise, and pharmacological interventions.

Conclusions:

• CHF and sarcopenia are interconnected conditions with overlapping pathophysiological pathways.
• Targeting shared mechanisms offers potential therapeutic benefits for elderly patients with CHF and muscle wasting.
• Further research into combined therapeutic strategies is crucial for improving patient outcomes.